Literature DB >> 15610671

Health Risks Associated with Visiting Friends and Relatives in Developing Countries.

Martha Fulford1, Jay S Keystone.   

Abstract

An increasingly large proportion of immigrants to developed countries is arriving from less developed countries in Africa, Asia, and Latin America. When these immigrants return to their country of origin to visit friends and relatives, they are at high risk of acquiring tropical infections, compared with other travelers. Immigrants who return to their country of origin to visit friends and relatives (VFRs) are more likely to travel to rural areas for long periods of time, to consume contaminated food and beverages, and to have more prolonged, intimate contact with local populations. As a group, they are less likely to seek pretravel advice or take antimalarial chemoprophylaxis. This article discusses the increased risk of tuberculosis, malaria, food- and waterborne illnesses, hepatitis A, and HIV and other sexually transmitted infections in VFRs.

Entities:  

Year:  2005        PMID: 15610671      PMCID: PMC7089204          DOI: 10.1007/s11908-005-0023-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  37 in total

1.  Travel epidemiology--a global perspective.

Authors:  Robert Steffen; Chiara deBernardis; Ana Baños
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

2.  Two worlds of malaria.

Authors:  Thomas E Wellems; Louis H Miller
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

3.  Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Arul Earnest; Nicholas I Paton
Journal:  BMJ       Date:  2002-08-17

4.  Infectious diseases in immigrants from the perspective of a tropical medicine referral unit.

Authors:  R López-Vélez; H Huerga; M C Turrientes
Journal:  Am J Trop Med Hyg       Date:  2003-07       Impact factor: 2.345

Review 5.  Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries.

Authors:  M M Thomson; R Nájera
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

6.  Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity.

Authors:  F G Cobelens; H van Deutekom; I W Draayer-Jansen; A C Schepp-Beelen; P J van Gerven; R P van Kessel; M E Mensen
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

7.  HIV transmission risk among sub-Saharan Africans in London travelling to their countries of origin.

Authors:  K A Fenton; M Chinouya; O Davidson; A Copas
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

8.  Travel medicine considerations for North American immigrants visiting friends and relatives.

Authors:  Nina Bacaner; Bill Stauffer; David R Boulware; Patricia F Walker; Jay S Keystone
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

9.  Survey of use of malaria prevention measures by Canadians visiting India.

Authors:  C C dos Santos; A Anvar; J S Keystone; K C Kain
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

10.  Typhoid fever in travelers: who should be targeted for prevention?

Authors:  E B Steinberg; R Bishop; P Haber; A F Dempsey; R M Hoekstra; J M Nelson; M Ackers; A Calugar; E D Mintz
Journal:  Clin Infect Dis       Date:  2004-07-01       Impact factor: 9.079

View more
  13 in total

1.  Imported malaria in the UK.

Authors:  Jane N Zuckerman
Journal:  BMJ       Date:  2008-07-03

2.  Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Authors:  Susan L Hills; Anne C Griggs; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Risk of latent and active tuberculosis infection in travellers: a systematic review and meta-analysis.

Authors:  Tanya R Diefenbach-Elstob; Balqis Alabdulkarim; Paromita Deb-Rinker; Jeffrey M Pernica; Guido Schwarzer; Dick Menzies; Ian Shrier; Kevin Schwartzman; Christina Greenaway
Journal:  J Travel Med       Date:  2021-01-06       Impact factor: 8.490

4.  World Malaria Day: Our story with malaria in Oman.

Authors:  Kowthar S Hassan
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

Review 5.  Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i.

Authors:  David M Callender; Gunther Hsue
Journal:  Hawaii Med J       Date:  2011-04

6.  Migration and malaria in europe.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-03-10       Impact factor: 2.576

Review 7.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

8.  The knowledge needs for Canadian paediatric emergency physicians in the diagnosis and management of tropical diseases: A national physician survey.

Authors:  Melissa Mengyan Wan; Quynh Doan; Niranjan Kissoon
Journal:  Paediatr Child Health       Date:  2020-03-30       Impact factor: 2.253

Review 9.  Management of imported malaria in Europe.

Authors:  Helena H Askling; Fabrice Bruneel; Gerd Burchard; Francesco Castelli; Peter L Chiodini; Martin P Grobusch; Rogelio Lopez-Vélez; Margaret Paul; Eskild Petersen; Corneliu Popescu; Michael Ramharter; Patricia Schlagenhauf
Journal:  Malar J       Date:  2012-09-17       Impact factor: 2.979

10.  GeoSentinel surveillance of illness in returned travelers, 2007-2011.

Authors:  Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman
Journal:  Ann Intern Med       Date:  2013-03-19       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.